Evidence map›Paper›PMID 34070083›Full record

ArticleGenes2021

Impacts of the Type I Toxin-Antitoxin System, SprG1/SprF1, on

Kinga Chlebicka, Emilia Bonar, Piotr Suder, Emeline Ostyn, Brice Felden, Benedykt Wladyka, Marie-Laure Pinel-Marie

Open access · goldAbstract read
In one paragraph

Article in Genes, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Thirty Years of sRNA-Mediated Regulation inInternational journal of molecular sciences · 2022
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Kinga ChlebickaDepartment of Analytical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.
Emilia BonarDepartment of Analytical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.
Piotr SuderDepartment of Analytical Chemistry and Biochemistry, Faculty of Materials Science and Ceramics, AGH University of Science and Technology, 31-007 Krakow, Poland.ORCID 0000-0003-4511-1241
Emeline OstynInserm, BRM [Bacterial Regulatory RNAs and Medicine]-UMR_S 1230, 35000 Rennes, France.
Brice FeldenInserm, BRM [Bacterial Regulatory RNAs and Medicine]-UMR_S 1230, 35000 Rennes, France.
Benedykt WladykaDepartment of Analytical Biochemistry, Faculty of Biochemistry, Biophysics and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.ORCID 0000-0002-9075-3529
Marie-Laure Pinel-MarieInserm, BRM [Bacterial Regulatory RNAs and Medicine]-UMR_S 1230, 35000 Rennes, France.ORCID 0000-0001-5128-0741
Inserm · FRJagiellonian University · PLAGH University of Krakow · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Type I toxin-antitoxin (TA) systems are widespread genetic modules in bacterial genomes. They express toxic peptides whose overexpression leads to growth arrest or cell death, whereas antitoxins regulate the expression of toxins, acting as labile antisense RNAs. The

Indexed as

AntitoxinsBacterial ProteinsCytoplasmGene ExpressionGene Expression Regulation, BacterialGenome, BacterialProteomeRNA, AntisenseStaphylococcus aureusToxin-Antitoxin SystemsAntitoxinsBacterial ProteinsProteomeRNA, Antisense2D-DIGEpeptide toxinsproteomicsRNA antitoxinStaphylococcus aureustoxin–antitoxin systems (type I)

Identifiers

PMID34070083
PMCPMC8158120
OpenAlexW3160292042

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.